id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0040-0103,FDA,FDA-2006-N-0040,Request for Extension of Comment Period from AABB,Other,Request for Extension,2016-02-18T05:00:00Z,2016,2,2016-02-18T05:00:00Z,,2016-02-18T17:48:43Z,,0,0,0900006480442297
FDA-2006-N-0040-0105,FDA,FDA-2006-N-0040,Request for Extension of Comment Period from America's Blood Centers,Other,Request for Extension,2016-02-18T05:00:00Z,2016,2,2016-02-18T05:00:00Z,,2016-02-18T17:55:35Z,,0,0,090000648044229d
FDA-2006-N-0040-0107,FDA,FDA-2006-N-0040,Request for Extension of Comment Period from Puget Sound Blood Center,Other,Request for Extension,2016-02-18T05:00:00Z,2016,2,2016-02-18T05:00:00Z,,2016-02-18T18:01:19Z,,0,0,090000648044229f
FDA-2006-N-0040-0106,FDA,FDA-2006-N-0040,Request for Extension of Comment Period from Plasma Protein Therapeutics Association (PPTA),Other,Request for Extension,2016-02-18T05:00:00Z,2016,2,2016-02-18T05:00:00Z,,2016-02-18T17:58:51Z,,0,0,090000648044229e
FDA-2006-N-0040-0104,FDA,FDA-2006-N-0040,Request for Extension of Comment Period from American Red Cross,Other,Request for Extension,2016-02-18T05:00:00Z,2016,2,2016-02-18T05:00:00Z,,2016-02-18T17:52:02Z,,0,0,090000648044229a